Roquette’s Ac-Di-Sol® Wins Advanced Technology Award at CPHI & PMEC China 2025

swipe

Celebrating Innovation in Drug Formulation

At one of the pharmaceutical industry’s most prominent global gatherings — CPHI & PMEC China 2025 — Roquette’s Ac-Di-Sol® was honored with the Advanced Technology Award in the Pharma Excipients category.

A Legacy of Performance, Reinforced by Innovation

Ac-Di-Sol® is a superdisintegrant made from internally cross-linked sodium carboxymethyl cellulose (NaCMC). Known for its excellent water uptake and rapid swelling properties, it enables faster tablet disintegration and drug dissolution — even at low use levels of just 1–2%.

Its fibrous morphology, low moisture content, and high purity contribute to consistent performance across a wide range of applications, making it a trusted choice for formulators seeking reliability and efficiency.

Looking Ahead

With rising regulatory pressures, cost constraints, and evolving patient expectations, pharmaceutical companies are seeking excipients that support multiple dosage forms and advanced manufacturing technologies. Ac-Di-Sol®’s recognition underscores the value of excipients backed by robust science and continuous innovation.

Discover More: